Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK16149 vs Pregabalin in DPNP Patients with Inadequate Response to Pregabalin
NCT06490484Phase 2Recruiting
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Apr 2024
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of crisugabalin besilate in diabetic polyneuropathy (DPN), sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started Apr 2024; status: recruiting.
02
Drugs
crisugabalin besilate
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT06490484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06490484.